Skip to content
LexBuild

Manufacturer of Controlled Substances Notice of Application; National Center For Natural Products Research (NIDA MPROJECT)

---
identifier: "/us/fr/2012-27441"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Manufacturer of Controlled Substances Notice of Application; National Center For Natural Products Research (NIDA MPROJECT)"
title_number: 0
title_name: "Federal Register"
section_number: "2012-27441"
section_name: "Manufacturer of Controlled Substances Notice of Application; National Center For Natural Products Research (NIDA MPROJECT)"
positive_law: false
currency: "2012-11-09"
last_updated: "2012-11-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2012-27441"
document_type: "notice"
publication_date: "2012-11-09"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "77 FR 67398"
fr_volume: 77
---

#  Manufacturer of Controlled Substances Notice of Application; National Center For Natural Products Research (NIDA MPROJECT)

Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 17, 2012, National Center for Natural Products Research—NIDA MProject, University of Mississippi, 135 Coy Waller Complex, University, Mississippi 38677, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

| Drug | Schedule |
| --- | --- |
| Marihuana (7360) | I |
| Tetrahydrocannabinols (7370) | I |

The company plans to cultivate marihuana for the National Institute on Drug Abuse for research approved by the Department of Health and Human Services.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than January 8, 2013.

Dated: November 1, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.